LAROCHE RICHARD F JR - 04 May 2023 Form 5 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role: Director
Signature: /s/ Richard F. LaRoche
Issuer symbol: NHC
Transactions as of: 04 May 2023
Net transactions value: $0
Form type: 5
Filing time: 04 May 2023, 18:16:12 UTC
Previous filing: 13 Feb 2023
Next filing: 03 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NHC	Common Stock (held in my name or my wife's name)						194,313	04 May 2023	Direct
holding	NHC	Common Stock (ROTH IRA)						115	04 May 2023	Direct
holding	NHC	Common Stock - Family LP (BFLP)						30,000	04 May 2023	GP
holding	NHC	Common Stock - Fam. Partnership (LR Ent.)						31,698	04 May 2023	Direct
holding	NHC	Common Stock - Fam. Partnership (LFLP)						96,000	04 May 2023	GP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NHC	Option to Purchase Common Stock [2023 Grant]	Award	$0	+7,500		$0.000000	7,500	04 May 2023	Common Stock	7,500	$55.75	Direct	F1
holding	NHC	Option to Purchase Common Stock [2019 Grant]						7,500	04 May 2023	Common Stock	7,500	$77.92	Direct
holding	NHC	Option to Purchase Common Stock [2020 Grant]						5,000	04 May 2023	Common Stock	5,000	$64.64	Direct
holding	NHC	Option to Purchase Common Stock [2021 Grant]						7,500	04 May 2023	Common Stock	7,500	$71.64	Direct
holding	NHC	Option to Purchase Common Stock [2022 Grant]						7,500	04 May 2023	Common Stock	7,500	$69.19	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).